Citation
Karp P.D. Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Designin Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development, Blackwell Science Ltd, 1997.
Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Design
Read more from SRI
-
Vaalia Health: Causal AI for precision healthcare
With healthcare shifting toward at-home solutions, Vaalia Health is building on SRI’s AI innovations to make sure that efficient care is also effective care.
-
Ashish Gehani named 2025 SRI Fellow
Senior principal computer scientist recognized for contributions in cybersecurity and trustworthy systems.
-
Major NIH study helps families manage sleep and screentime
SRI Fellow Fiona Baker: Longitudinal research like the SRI-supported ABCD study is crucial for understanding how modern life shapes developing brains.